96 related articles for article (PubMed ID: 36170764)
1. Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.
Lewis JW; Loughran J; Deng L; Varghese J; Clark S; Harrison C; Gacetta M; Jernigan JA; Fleming-Dutra KE
Emerg Infect Dis; 2022 Nov; 28(11):2338-2341. PubMed ID: 36170764
[TBL] [Abstract][Full Text] [Related]
2. Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021.
Dale AP; Almendares O; Howard BJ; Burnett E; Prasai S; Arons M; Collins J; Duffy N; Pandit U; Brady S; White JR; Garrett B; Kirking HL; Sunenshine R; Tate JE; Scott SE
Clin Infect Dis; 2022 Aug; 75(1):e20-e26. PubMed ID: 35413107
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
4. Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
Magro M; Parriott A; Mitsunaga T; Epson E
Emerg Infect Dis; 2022 Aug; 28(8):1734-1736. PubMed ID: 35732196
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines Against Infection During an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta (B.1.351) Variant in a Skilled Nursing Facility: Virginia, March-April 2021.
Moline HL; Keaton A; Rice W; Varghese J; Deng L; Waters A; Barringer A; Winston D; Fields V; Slifka KJ; Verani JR; Schrag SJ; Jernigan J; Tate JE; Fleming-Dutra KE
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S155-S158. PubMed ID: 35758873
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.
Silverman RA; Ceci A; Cohen A; Helmick M; Short E; Bordwine P; Friedlander MJ; Finkielstein CV
Emerg Infect Dis; 2022 Jul; 28(7):1313-1320. PubMed ID: 35731137
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunity.
Pierobon A; Zotto AD; Antico A; De Antoni ME; Vianello L; Gennari M; Di Caprio A; Russo F; Brambilla G; Saugo M
Clin Microbiol Infect; 2022 Apr; 28(4):614.e5-614.e7. PubMed ID: 34958917
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.
Kimball A; Hatfield KM; Arons M; James A; Taylor J; Spicer K; Bardossy AC; Oakley LP; Tanwar S; Chisty Z; Bell JM; Methner M; Harney J; Jacobs JR; Carlson CM; McLaughlin HP; Stone N; Clark S; Brostrom-Smith C; Page LC; Kay M; Lewis J; Russell D; Hiatt B; Gant J; Duchin JS; Clark TA; Honein MA; Reddy SC; Jernigan JA; ;
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(13):377-381. PubMed ID: 32240128
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
Grewal R; Kitchen SA; Nguyen L; Buchan SA; Wilson SE; Costa AP; Kwong JC
BMJ; 2022 Jul; 378():e071502. PubMed ID: 35793826
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021.
Cavanaugh AM; Fortier S; Lewis P; Arora V; Johnson M; George K; Tobias J; Lunn S; Miller T; Thoroughman D; Spicer KB
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):639-643. PubMed ID: 33914720
[TBL] [Abstract][Full Text] [Related]
13. Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
Skowronski DM; Setayeshgar S; Zou M; Prystajecky N; Tyson JR; Sbihi H; Fjell CD; Galanis E; Naus M; Patrick DM; El Adam S; Ahmed MA; Kim S; Henry B; Hoang LMN; Sadarangani M; Jassem AN; Krajden M
J Infect Dis; 2022 Aug; 226(1):485-496. PubMed ID: 35084500
[TBL] [Abstract][Full Text] [Related]
14. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
Arons MM; Hatfield KM; Reddy SC; Kimball A; James A; Jacobs JR; Taylor J; Spicer K; Bardossy AC; Oakley LP; Tanwar S; Dyal JW; Harney J; Chisty Z; Bell JM; Methner M; Paul P; Carlson CM; McLaughlin HP; Thornburg N; Tong S; Tamin A; Tao Y; Uehara A; Harcourt J; Clark S; Brostrom-Smith C; Page LC; Kay M; Lewis J; Montgomery P; Stone ND; Clark TA; Honein MA; Duchin JS; Jernigan JA;
N Engl J Med; 2020 May; 382(22):2081-2090. PubMed ID: 32329971
[TBL] [Abstract][Full Text] [Related]
15. Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectiveness.
Smoll N; Walker J; Hassan Al Imam M; Auriac J; Andrews R; Jeremijenko A; Kirk M; Khandaker G
Commun Dis Intell (2018); 2022 Aug; 46():. PubMed ID: 35981815
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
Glatman-Freedman A; Hershkovitz Y; Kaufman Z; Dichtiar R; Keinan-Boker L; Bromberg M
Emerg Infect Dis; 2021 Nov; 27(11):2919-2922. PubMed ID: 34570694
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents.
Kim YY; Choe YJ; Kim J; Kim RK; Jang EJ; Park SK; Lim DS; Yi S; Lee S; Kwon GY; Shin JY; Choi SY; Jeong MJ; Park YJ
Emerg Infect Dis; 2022 Nov; 28(11):2165-2170. PubMed ID: 36191615
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
Mazagatos C; Delgado-Sanz C; Monge S; Pozo F; Oliva J; Sandonis V; Gandarillas A; Quiñones-Rubio C; Ruiz-Sopeña C; Gallardo-García V; Basile L; Barranco-Boada MI; Hidalgo-Pardo O; Vazquez-Cancela O; García-Vázquez M; Fernández-Sierra A; Milagro-Beamonte A; Ordobás M; Martínez-Ochoa E; Fernández-Arribas S; Lorusso N; Martínez A; García-Fulgueiras A; Sastre-Palou B; Losada-Castillo I; Martínez-Cuenca S; Rodríguez-Del Águila M; Latorre M; Larrauri A;
Influenza Other Respir Viruses; 2022 Nov; 16(6):1014-1025. PubMed ID: 35880469
[TBL] [Abstract][Full Text] [Related]
20. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
